Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CX3CR1 ELISA Kit (AC2745)
Cat.#: ASET-1334
Specifications
Description Human CX3CR1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CX3CR1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.47 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 150-2400 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2248 Mouse Dab1 ELISA Kit (AC3659) Quantitative inquiry ASET-1470 Human GCH1 ELISA Kit (AC2881) Quantitative inquiry ASET-2086 Human ICA69 ELISA Kit (AC3497) Quantitative inquiry ASET-1913 Rat Tau ELISA Kit (AC3324) Quantitative inquiry ASET-1144 Human Neuroglobin ELISA Kit (AC2555) Quantitative inquiry ASET-1747 Porcine Angiogenin ELISA Kit (AC3158) Quantitative inquiry ASET-2107 Rat Slit2 ELISA Kit (AC3518) Quantitative inquiry ASET-1910 Human C Peptide ELISA Kit (AC3321) Quantitative inquiry ASET-1892 Rat G-Protein Coupled Receptor 30 ELISA Kit (AC3303) Quantitative inquiry ASET-2252 Human NKCC1 ELISA Kit (AC3663) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket